SCHEMBL6748159

SCHEMBL6748159

O=P(O)(O)N(c1ccccc1)c1ccccc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.39
ACP3 P15309 1/20 0.39
HTT P42858 3/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TP53 P04637 1/20 0.36
ALDH1A1 P00352 2/20 0.35
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA5A P35218 1/20 0.34
NPSR1 Q6W5P4 2/20 0.33
MAPT P10636 1/20 0.33
PTK2B Q14289 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9386229 0.81 LMNA (0.39) POLBACP3HTTKMT2AMEN1
SCHEMBL2309806 0.80 MEN1 (0.48) HTTKMT2AMEN1ALDH1A1CA2
SCHEMBL8530739 0.80 MEN1 (0.48) HTTKMT2AMEN1ALDH1A1CA2
Hydrochloric Acid SCHEMBL27627985 0.78 MEN1 (0.46) HTTKMT2AMEN1ALDH1A1CA2
SCHEMBL7740408 0.76 ALDH1A1 (0.36) ACP3HTTKMT2AMEN1SMN1; SMN2
SCHEMBL10881554 0.76 SMN1; SMN2 (0.41) POLBACP3SMN1; SMN2ALDH1A1CA2
SCHEMBL11764058 0.75 SIGMAR1 (0.46) ACP3CA2PTK2BHDAC8NPC1
Methane SCHEMBL10785614 0.75 SMN1; SMN2 (0.39) POLBACP3SMN1; SMN2ALDH1A1CA2
SCHEMBL7740475 0.74 ALDH1A1 (0.34) ACP3HTTKMT2AMEN1SMN1; SMN2
SCHEMBL5892 0.71 HTT (0.44) POLBHTTKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142946-A1 Modified nucleosides and nucleotides and use thereof CHATTOPADHYAYA JYOTI (SE) 2004-07-22 US claimed
EP-1332150-A1 MODIFIED NUCLEOSIDES AND NUCLEOTIDES AND USE THEREOF Chattopadhyaya, Jyoti (SE) 2003-08-06 EP claimed
WO-2002038578-A1 MODIFIED NUCLEOSIDES AND NUCLEOTIDES AND USE THEREOF CHATTOPADHYAYA JYOTI (SE) 2002-05-16 WO claimed
US-5721350-A Deuterated nucleosides CHATTOPADHYAYA JYOTI (SE) 1998-02-24 US claimed
WO-1993025566-A1 DEUTERATED NUCLEOSIDES CHATTOPADHYAYA JYOTI (SE) 1993-12-23 WO claimed
EP-0335409-B1 Pyrimidine derivatives, processes for their production and herbicidal compositions containing them KUMIAI CHEMICAL INDUSTRY CO (JP) 1994-12-07 EP disclosed
US-4969949-A NONPHYTOTOXIC KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 1990-11-13 US disclosed
EP-0335409-A2 Pyrimidine derivatives, processes for their production and herbicidal compositions containing them KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 1989-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142946-A1 Modified nucleosides and nucleotides and use thereof RNASEH1, RNASEL, NSUN2 POLB 215/4885ACP3 3518/4885HTT 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.